Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C14H23BrNO3.I |
| Molecular Weight | 460.146 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[I-].CC[N+](C)(CC)CCC(C)OC(=O)C1=CC=C(Br)O1
InChI
InChIKey=KROWHJNUJMVHNU-UHFFFAOYSA-M
InChI=1S/C14H23BrNO3.HI/c1-5-16(4,6-2)10-9-11(3)18-14(17)12-7-8-13(15)19-12;/h7-8,11H,5-6,9-10H2,1-4H3;1H/q+1;/p-1
Fubromegan, a ganglionic blocking agent as an iodide salt, FUBROGONIUM IODIDE was used in Russia in patients with peptic ulcer and in the symptomatic therapy of patients with pneumoconioses. The antispasmodic effect of fubromegan was due to the effect on m- and n-cholinergic structures of smooth muscles and ganglia.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Roentgenological studies on the effect of fubromegan in dyskinesias of the biliary tract]. | 1961 |
|
| [Quateleron and Fubromegan in the treatment of peptic ulcer]. | 1961 Dec |
|
| [Effect of fubromegan on the motor-evacuation activity of the stomach (roentgenological studies)]. | 1961 Nov |
|
| [Use of a new domestic preparation fubromegan in the treatment of peptic ulcer]. | 1961 Nov |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29696
Created by
admin on Fri Dec 15 16:08:14 GMT 2023 , Edited by admin on Fri Dec 15 16:08:14 GMT 2023
|
||
|
NCI_THESAURUS |
C66886
Created by
admin on Fri Dec 15 16:08:14 GMT 2023 , Edited by admin on Fri Dec 15 16:08:14 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB07824MIG
Created by
admin on Fri Dec 15 16:08:14 GMT 2023 , Edited by admin on Fri Dec 15 16:08:14 GMT 2023
|
PRIMARY | |||
|
2433
Created by
admin on Fri Dec 15 16:08:14 GMT 2023 , Edited by admin on Fri Dec 15 16:08:14 GMT 2023
|
PRIMARY | |||
|
C007788
Created by
admin on Fri Dec 15 16:08:14 GMT 2023 , Edited by admin on Fri Dec 15 16:08:14 GMT 2023
|
PRIMARY | |||
|
71529
Created by
admin on Fri Dec 15 16:08:14 GMT 2023 , Edited by admin on Fri Dec 15 16:08:14 GMT 2023
|
PRIMARY | |||
|
CHEMBL2110930
Created by
admin on Fri Dec 15 16:08:14 GMT 2023 , Edited by admin on Fri Dec 15 16:08:14 GMT 2023
|
PRIMARY | |||
|
3690-58-2
Created by
admin on Fri Dec 15 16:08:14 GMT 2023 , Edited by admin on Fri Dec 15 16:08:14 GMT 2023
|
PRIMARY | |||
|
DTXSID90958102
Created by
admin on Fri Dec 15 16:08:14 GMT 2023 , Edited by admin on Fri Dec 15 16:08:14 GMT 2023
|
PRIMARY | |||
|
4791MN0PVE
Created by
admin on Fri Dec 15 16:08:14 GMT 2023 , Edited by admin on Fri Dec 15 16:08:14 GMT 2023
|
PRIMARY | |||
|
100000080671
Created by
admin on Fri Dec 15 16:08:14 GMT 2023 , Edited by admin on Fri Dec 15 16:08:14 GMT 2023
|
PRIMARY | |||
|
C65776
Created by
admin on Fri Dec 15 16:08:14 GMT 2023 , Edited by admin on Fri Dec 15 16:08:14 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD
